RESUMO
The rate-limiting step in cholesterol biosynthesis in mammals is catalyzed by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, a four-electron oxidoreductase that converts HMG-CoA to mevalonate. The crystal structure of HMG-CoA reductase from Pseudomonas mevalonii was determined at 3.0 angstrom resolution by multiple isomorphous replacement. The structure reveals a tightly bound dimer that brings together at the subunit interface the conserved residues implicated in substrate binding and catalysis. These dimers are packed about a threefold crystallographic axis, forming a hexamer with 23 point group symmetry. Difference Fourier studies reveal the binding sites for the substrates HMG-CoA and reduced or oxidized nicotinamide adenine dinucleotide [NAD(H)] and demonstrate that the active sites are at the dimer interfaces. The HMG-CoA is bound by a domain with an unusual fold, consisting of a central alpha helix surrounded by a triangular set of walls of beta sheets and alpha helices. The NAD(H) is bound by a domain characterized by an antiparallel beta structure that defines a class of dinucleotide-binding domains.
Assuntos
Hidroximetilglutaril-CoA Redutases/química , Pseudomonas/enzimologia , Acil Coenzima A/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Gráficos por Computador , Cristalografia por Raios X , Análise de Fourier , Hidroximetilglutaril-CoA Redutases/metabolismo , Modelos Moleculares , Dados de Sequência Molecular , NAD/metabolismo , Dobramento de Proteína , Estrutura Secundária de ProteínaRESUMO
HMG-CoA lyase, the putative second intracellular enzyme of mevalonate catabolism in Pseudomonas mevalonii (which we previously referred to as Pseudomonas sp. M (Gill et al. (1984) J. Bacteriol. 160, 294-298, Gill et al. (1985) J. Biol. Chem. 250, 9393-9398 and Sherban, M.S., Thesis, Purdue University), was purified 650-fold from cell extracts to a specific activity of 22 mumol acetyl-CoA formed per min per mg protein. This represents the first published report of the partial purification and characterization of an HMG-CoA lyase from a prokaryotic source. Cleavage of HMG-CoA produced acetyl-CoA and acetoacetate. Activity was optimal at pH 8.8 and was undetectable at or below pH 6.5. The estimated Km for S-HMG-CoA was 100 microM. Both a reduced thiol and Mg2+ or Mn2+ were required for activity. While Mn2+ was preferred at low concentrations, 1 mM or higher concentrations of either cation supported the same maximum velocity. An apparent native Mr of 40,400 +/- 3100 was estimated from gel filtration and sucrose density gradient ultracentrifugation data.
Assuntos
Oxo-Ácido-Liases/metabolismo , Pseudomonas/enzimologia , Cátions Bivalentes , Cromatografia , Cromatografia em Gel , Eletroforese em Gel de Poliacrilamida , Concentração de Íons de Hidrogênio , Cinética , Ácido Mevalônico/metabolismo , Peso Molecular , Oxo-Ácido-Liases/isolamento & purificaçãoRESUMO
Mutant 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductases of the halophilic archaeon Haloferax volcanii were constructed to test the proposed mechanism that phosphorylation downregulates the activity of higher eukarya HMG-CoA reductases via charge-charge interaction with the active site histidine. To first verify the sequence-based inference that His 398 is the catalytic histidine of the H. volcanii enzyme, enzyme H398Q was constructed, purified, and assayed for catalysis of three reactions: [1] reductive deacylation of HMG-CoA, [2] reduction of mevaldehyde, and [3] oxidative acylation of mevaldehyde. Enzyme H398Q had low activity for catalysis of reaction [1] or [3], but readily catalyzed mevaldehyde reduction. By analogy to hamster HMG-CoA reductase, we conclude that His 398 is the active site histidine. Mutant forms of the 403-residue H. volcanii enzyme were constructed to model phosphorylation and infer whether attenuated activity involved interaction with His 398. Chimeric H. volcanii-hamster enzymes constructed in an effort to create an active, phosphorylatable chimeric enzyme were inactive or not phosphorylated. We therefore added Asp at position 404 to mimic the introduction of negative charge that would accompany phosphorylation. Enzyme 404D/H398Q was inactive for reaction [1] or [3], but catalyzed reaction [2] at 35% the wild-type rate. These observations are consistent with the model that attenuation of catalytic activity results from an ionic interaction between the imidazolium cation of His 398 and the carboxylate anion of Asp 404.
Assuntos
Archaea/enzimologia , Histidina/química , Hidroximetilglutaril-CoA Redutases/química , Sequência de Aminoácidos , Animais , Catálise , Cricetinae , Humanos , Hidroximetilglutaril-CoA Redutases/metabolismo , Cinética , Mesocricetus , Dados de Sequência Molecular , Fosforilação , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/metabolismo , Alinhamento de SequênciaRESUMO
The mvaAB operon of Pseudomonas mevalonii encodes HMG-CoA reductase (EC 1.1.1.88) and HMG-CoA lyase (EC 4.1.3.4), enzymes that catalyze the initial reactions of mevalonate catabolism in this organism. Expression of this operon is regulated by the constitutively expressed transcriptional activator protein MvaT that binds in vitro to an upstream regulatory element. Mevalonate is essential for activation of transcription in vivo, and in vitro data demonstrated that MvaT binds to the mvaAB cis-regulatory element in the absence of mevalonate with a Kd,app of 2 nM. Purification of MvaT enriched for two polypeptides of approximate molecular mass 15 kDa and 16 kDa, designated P15 and P16. MvaT, assayed by its DNA-binding activity, comigrated with P15 and P16 during DNA-affinity chromatography, size-exclusion chromatography, and sucrose density gradient centrifugation. P15 and P16 also comigrated during denaturing isoelectric focusing of purified MvaT. Treatment of MvaT with dimethylsuberimidate formed a 31-kDa polypeptide complex that contained N-terminal sequences from P15 and P16. The apparent association of P15 and P16 in solution and their copurification with MvaT activity strongly suggests that MvaT is comprised of these two subunits. Size-exclusion chromatography gave an estimated molecular mass for MvaT of 33 kDa. A partial DNA sequence of the P16 gene was obtained using PCR employing degenerate primers directed against the N-termini of P15 and P16. P16 appears to be comprised of at least 128 aminoacyl residues having a predicted molecular mass of 14.3 kDa.
Assuntos
Proteínas de Bactérias , Óperon/genética , Pseudomonas/enzimologia , Transativadores/química , Fatores de Transcrição/química , Ativação Transcricional/fisiologia , Sequência de Aminoácidos , Sequência de Bases , Clonagem Molecular , Reagentes de Ligações Cruzadas/metabolismo , Proteínas de Ligação a DNA/química , Dimerização , Dimetil Suberimidato/metabolismo , Regulação Bacteriana da Expressão Gênica/genética , Hidroximetilglutaril-CoA Redutases/genética , Ácido Mevalônico/metabolismo , Dados de Sequência Molecular , Peso Molecular , Oxo-Ácido-Liases/genética , Análise de Sequência de DNARESUMO
Comparison of the inferred amino acid sequence of orf AF1736 of Archaeoglobus fulgidus to that of Pseudomonas mevalonii HMG-CoA reductase suggested that AF1736 might encode a Class II HMG-CoA reductase. Following polymerase chain reaction-based cloning of AF1736 from A. fulgidus genomic DNA and expression in Escherichia coli, the encoded enzyme was purified to apparent homogeneity and its enzymic properties were determined. Activity was optimal at 85 degrees C, deltaHa was 54 kJ/mol, and the statin drug mevinolin inhibited competitively with HMG-CoA (Ki 180 microM). Protonated forms of His390 and Lys277, the apparent cognates of the active site histidine and lysine of the P. mevalonii enzyme, appear essential for activity. The mechanism proposed for catalysis of P. mevalonii HMG-CoA reductase thus appears valid for A. fulgidus HMG-CoA reductase. Unlike any other HMG-CoA reductase, the A. fulgidus enzyme exhibits dual coenzyme specificity. pH-activity profiles for all four reactions revealed that optimal activity using NADP(H) occurred at a pH from 1 to 3 units more acidic than that observed using NAD(H). Kinetic parameters were therefore determined for all substrates for all four catalyzed reactions using either NAD(H) or NADP(H). NADPH and NADH compete for occupancy of a common site. k(cat)[NAD(H)]/k(cat)[NADP(H)] varied from unity to under 70 for the four reactions, indicative of slight preference for NAD(H). The results indicate the importance of the protonated status of active site residues His390 and Lys277, shown by altered K(M) and k(cat) values, and indicate that NAD(H) and NADP(H) have comparable affinity for the same site.
Assuntos
Archaeoglobus/enzimologia , Hidroximetilglutaril-CoA Redutases/metabolismo , Sequência de Bases , Catálise , Concentração de Íons de Hidrogênio , Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia , Cinética , Lovastatina/farmacologia , Oligonucleotídeos , Especificidade por Substrato , TermodinâmicaRESUMO
Rat hepatocytes were used to demonstrate rapid, transient effects on the modulation state (defined as the fraction of the enzyme present in the catalytically active form) of 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA reductase, E.C. 1.1.1.34). Insulin elevated, while glucagon, cAMP or cGMP lowered HMG-CoA reductase modulation state within 10 to 15 min. These changes were accompanied by a parallel change in sterol synthesis. Total HMG-CoA reductase activity was not altered. Rapid modulation of HMG-CoA reductase activity therefore constitutes a viable in vivo control mechanism. By contrast to the hormones and second messengers, mevalonolactone lowered both HMG-CoA reductase modulation state and total reductase quantity.
Assuntos
Bucladesina/farmacologia , AMP Cíclico/metabolismo , GMP Cíclico/análogos & derivados , GMP Cíclico/metabolismo , Dibutiril GMP Cíclico/farmacologia , Hidroximetilglutaril-CoA Redutases/metabolismo , Fígado/enzimologia , Animais , Glucagon/farmacologia , Técnicas In Vitro , Insulina/farmacologia , Cinética , Fígado/efeitos dos fármacos , Masculino , Ácido Mevalônico/análogos & derivados , Ácido Mevalônico/farmacologia , Ratos , Ratos EndogâmicosAssuntos
Hidroximetilglutaril-CoA Redutases , Proteínas Serina-Treonina Quinases , Proteínas Quinases Ativadas por AMP , Animais , Galinhas , Citosol/enzimologia , Jejum , Microssomos Hepáticos/enzimologia , Peso Molecular , Complexos Multienzimáticos , Proteínas Quinases , Coelhos , Ratos , Ratos Endogâmicos , Especificidade da Espécie , Especificidade por Substrato , SuínosAssuntos
Oxirredutases do Álcool/análise , Células L/enzimologia , Microssomos Hepáticos/enzimologia , Trifosfato de Adenosina/farmacologia , Animais , Radioisótopos de Carbono , Colesterol/farmacologia , Cromatografia em Camada Fina , Coenzimas , Fibroblastos/enzimologia , Glutaratos , Cinética , Magnésio/farmacologia , Métodos , Ácido Mevalônico/análise , Camundongos , Microquímica , Fosfatidilcolinas/farmacologia , Ratos , Fatores de Tempo , TrítioAssuntos
Colesterol/biossíntese , Hidroximetilglutaril-CoA Redutases/metabolismo , Animais , Proteínas de Transporte/metabolismo , Ciclo Celular , Membrana Celular/enzimologia , Células Cultivadas , LDL-Colesterol/metabolismo , Humanos , Hidroximetilglutaril-CoA Redutases/genética , Hiperlipoproteinemia Tipo II/enzimologia , Fígado/enzimologia , Lipídeos de Membrana/metabolismo , Microssomos Hepáticos/enzimologia , Fosforilação , Plantas/enzimologia , Pseudomonas/enzimologia , Ratos , Saccharomyces cerevisiae/enzimologiaAssuntos
Fígado/metabolismo , Ácido Mevalônico/biossíntese , Acetatos/metabolismo , Ar , Oxirredutases do Álcool/metabolismo , Animais , Bicarbonatos , Isótopos de Carbono , Coenzima A/metabolismo , Glutaratos/biossíntese , Hexosefosfatos/metabolismo , Fígado/citologia , Fígado/enzimologia , Malonatos/metabolismo , Ácido Mevalônico/isolamento & purificação , NADP/metabolismo , Ratos , UltracentrifugaçãoAssuntos
Acetatos/metabolismo , Cloranfenicol/farmacologia , Cicloeximida/farmacologia , Fígado/metabolismo , Animais , Dióxido de Carbono/metabolismo , Isótopos de Carbono , Colesterol/biossíntese , Depressão Química , Ácidos Graxos/biossíntese , Feminino , Fígado/efeitos dos fármacos , Ácido Mevalônico/metabolismo , Ratos , Fatores de TempoRESUMO
Baginsky, Marietta L. (University of California, San Francisco Medical Center, San Francisco), and Victor W. Rodwell. Metabolism of pipecolic acid in a Pseudomonas species. IV. Electron transport particle of Pseudomonas putida. J. Bacteriol. 92:424-432. 1966.-Enzymes of Pseudomonas putida P2 catalyzing oxidation of pipecolate to Delta(1)-piperideine-6-carboxylate are located in a subcellular fraction sedimenting at 105,000 x g. Since this fraction resembles the mammalian electron transport particle in both chemical composition and enzymatic activities, it was termed Pseudomonas P2 electron transport particle (P2-ETP). P2-ETP contains flavin adenine dinucleotide, flavin mononucleotide, iron, copper, and both b- and c-type cytochromes. The reduced type b cytochrome has absorption maxima at 558 to 559, 530, and 427 mmu. Its oxidized pyridine hemochromogen has an absorption maximum at 406 mmu, with a shoulder at 564 mmu. On dithionite reduction, absorption bands with maxima at 556, 522, and 418 mmu are obtained. The reduced type c cytochrome has absorption maxima at 552, 520, and 422 mmu; its reduced pyridine hemochromogen has maxima at 551, 516 to 519, and 418 mmu. No type a cytochrome was detected. P2-ETP catalyzes oxidation of pipecolate and of reduced nicotinamide adenine dinucleotide (NADH(2)) by oxygen. It can also oxidize these compounds, as well as succinate and reduced nicotinamide adenine dinucleotide phosphate, with 2,6-dichlorophenol-indophenol as electron acceptor. Mammalian cytochrome c can be used as an alternate artificial electron acceptor for the oxidation of pipecolate and succinate, but not for oxidation of NADH(2).
RESUMO
DNA upstream of the transcription start site of the mvaAB operon of Pseudomonas mevalonii, which encodes 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (EC 1.1.1.88) and HMG-CoA lyase (EC 4.1.3.4), contains a cis-acting regulatory element which functions in the response to mevalonate. The regulatory element resides within a 36-bp region located from 48 to 84 bp upstream of the transcription start site of mvaA. This location was inferred from the beta-galactosidase activities of P. mevalonii harboring plasmid-encoded mvaA-lacZ fusions induced by mevalonate and by DNA gel retardation and competition assays. While protein from P. mevalonii grown on mevalonate produced a band shift, protein from cells grown on succinate gave no band shift, even when mevalonate was added. The operator contains three 10-bp direct repeats with the consensus sequence TGGGTACAGT, which may be important for regulation of the mvaAB operon.
Assuntos
Óperon , Pseudomonas/genética , Sequências Reguladoras de Ácido Nucleico , Sequência de Bases , Ligação Competitiva , Sondas de DNA , DNA Bacteriano/metabolismo , Genes Bacterianos , Hidroximetilglutaril-CoA Redutases/genética , Dados de Sequência Molecular , Plasmídeos , Pseudomonas/enzimologia , Sequências Repetitivas de Ácido Nucleico , Transcrição GênicaRESUMO
Assay of HMG-CoA reductase kinase activity requires HMG-CoA reductase (reductase, E.C. 1.1.1.34) free of associated reductase kinase. Microsomal reductase insensitive to inactivation by Mg-nucleotides alone may be prepared by heating microsomes at 50 degrees C for 15 min. The reductase in these microsomes may subsequently be inactivated by Mg-nucleotides only after addition of reductase kinase. Inactivation is a linear function of time and of cytosol protein concentration and may be reversed by treatment with a phosphoprotein phosphatase. The extent of inactivation observed under standard conditions provides an assay for reductase kinase activity. Factors present in cytosol that hinder measurement of either reductase or reductase kinase activity must be removed or inhibited. Reductase phosphatase is inhibited by 50 mM NaF. Reductase kinase kinase activity is not expressed under the assay conditions used. Mg-Nucleotide-independent inhibitors of reductase activity are removed by chromatography on DEAE-Sephacel or Blue Sepharose. Mevalonate kinase and reductase kinase are separable by chromatography on DEAE-Sephacel or Sephadex G-200. We describe a rapid chromatographic procedure for separating reductase kinase of crude fractions from mevalonate kinase and from Mg-nucleotide-independent inhibitors of reductase activity. The 1.0 M KCl eluate from DEAE-Sephacel contains all of the cytosol reductase kinase activity. This method is applicable to measurement of reductase kinase activity in cytosol or more purified fractions.
Assuntos
Inibidores de Hidroximetilglutaril-CoA Redutases , Complexos Multienzimáticos/metabolismo , Fosfotransferases (Aceptor do Grupo Álcool) , Fosfotransferases/metabolismo , Proteínas Quinases/metabolismo , Proteínas Serina-Treonina Quinases , Proteínas Quinases Ativadas por AMP , Difosfato de Adenosina/metabolismo , Animais , Cromatografia por Troca Iônica , Ácido Edético/farmacologia , Feminino , Métodos , Ratos , Ratos EndogâmicosRESUMO
(S)-3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA), the physiologic substrate of HMG-CoA reductase and of HMG-CoA lyase, is available commercially only as (R,S)-HMG-CoA, a mixture of diastereomers. To provide (S)-HMG-CoA for our continuing investigation of HMG-CoA reductase, we used homogeneous, overexpressed Pseudomonas mevalonii HMG-CoA reductase (EC 1.1.1.88) and an NAD(+)-regenerating system to convert (R)-mevalonate to (S)-HMG-CoA with an overall yield in excess of 50%. We also used P. mevalonii HMG-CoA lyase (EC 4.1.3.4) to prepare (R)-HMG-CoA from (R,S)-HMG-CoA. Each diastereomer was then isolated by ion-exchange chromatography. Large-scale preparations provide for economical production of (S)-HMG-CoA, particularly when recovered coenzyme A is recycled. (S)-HMG-CoA was evaluated as a substrate, and (R)-HMG-CoA as an inhibitor, for the P. mevalonii enzymes HMG-CoA reductase and HMG-CoA lyase, and for Syrian hamster HMG-CoA reductase (EC 1.1.1.34). For both HMG-CoA reductases, (R)-HMG-CoA inhibited competitively with respect to (S)-HMG-CoA. The ratio Ki/Km was 0.7 +/- 0.1 and 0.6 +/- 0.2 for the bacterial and hamster enzymes, respectively. By contrast, (R)-HMG-CoA did not inhibit P. mevalonii HMG-CoA lyase.
Assuntos
Acil Coenzima A/biossíntese , Hidroximetilglutaril-CoA Redutases/metabolismo , Oxo-Ácido-Liases/metabolismo , Acil Coenzima A/isolamento & purificação , Animais , Cromatografia por Troca Iônica , Colorimetria , Cricetinae , Cinética , Mesocricetus , Pseudomonas/enzimologia , Proteínas Recombinantes/metabolismo , Espectrofotometria Ultravioleta , EstereoisomerismoRESUMO
Involvement in catalysis of a histidyl residue of Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase was suggested by the ability of diethyl pyrocarbonate to abolish catalytic activity, accompanying spectral changes, and reactivation by hydroxylamine. The 7 histidines present in the catalytic domain of the hamster enzyme were changed to glutamine (His474, His487, His634, His751, His860, and His865), lysine (His865), or tyrosine (His868). Overexpression in Escherichia coli yielded six soluble mutant proteins, one insoluble protein (H634Q), and one which was degraded in vivo (H487Q). Following purification to homogeneity, mutant enzymes H474Q, H751Q, H860Q, and H868Y had essentially wild-type catalytic activity, while mutant enzymes H865K and H865Q had less than 0.6% wild-type activity. The low activity of mutant enzymes H865K and H865Q is unlikely to reflect altered structural integrity since both chromatographed on affinity supports like wild-type enzyme and had Km values for (S)-HMG-CoA (31 and 16 microM) and for NADPH (60 and 24 microM) close to those for wild-type enzyme (31 and 52 microM for (S)-HMG-CoA and NADPH, respectively). His865 of hamster HMG-CoA reductase, the histidine of the consensus Leu-Val-Xaa-Ser-His-Met-Xaa-Xaa-Asn-Arg-Ser motif and the only histidine conserved among the catalytic domains of all HMG-CoA reductases, thus appears to be a general acid/base functional in catalysis.
Assuntos
Histidina/metabolismo , Hidroximetilglutaril-CoA Redutases/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Catálise , Sequência Conservada , Cricetinae , DNA , Dietil Pirocarbonato/farmacologia , Eletroforese em Gel de Poliacrilamida , Ativação Enzimática , Concentração de Íons de Hidrogênio , Hidroximetilglutaril-CoA Redutases/genética , Inibidores de Hidroximetilglutaril-CoA Redutases , Cinética , Mesocricetus , Dados de Sequência Molecular , Mutagênese Sítio-DirigidaRESUMO
We have cloned, determined the primary structure of, and overexpressed in Escherichia coli the gene mvaA, which is the 1,287-base structural gene for the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase [EC 1.1.1.88] of Pseudomonas mevalonii. The amino acid composition of HMG-CoA reductase agreed with that predicted from the nucleotide sequence of mvaA, and DNA-derived sequences were identical to all experimentally determined peptide sequences. Overexpression of mvaA in E. coli yielded quantities of HMG-CoA reductase over 1,500-fold higher than those present in control cultures. Comparison of the primary structure of the P. mevalonii enzyme with the DNA-derived primary structure for a mammalian HMG-CoA reductase revealed two regions of similarity suggestive of functional relatedness. An open reading frame, ORF1, lies on the 3' side of mvaA, and a potential ribosome-binding site for ORF1 overlaps the termination codon of mvaA.